Delivery Order SPE2DB20D3303-SPE2DB25FA2FM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 ml vials, with a contract ceiling value of $43,208.69. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a routine pharmaceutical procurement under a competitively awarded, non-set-aside contract vehicle. The work will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,324.69 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $4,893.47 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 ml vials. This non-competitive, firm fixed-price delivery order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a routine pharmaceutical procurement within the...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.3K to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml formulations. This competitively awarded, non-set-aside contract was executed on April 28, 2025, with an ultimate completion date of April 29, 2025, and is priced on a firm fixed-price basis. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.98 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml vials. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 26, 2025. The award was issued on September 25, 2025, and the pharmaceutical will be delivered to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with a contract ceiling value of $31,796.89. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,977.94 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL formulations. The order was competitively awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a firm fixed-price transaction with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a $35.3K delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens (3mL) with a firm fixed price and completion deadline of September 15, 2025. This is a competitively awarded contract with no set-aside designation, issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pen 3 mL formulations under a firm fixed price contract structure. The order, valued at $1,253.32, is effective through August 7, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,921.88 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on August 13, 2025, one day after the award date of August 12, 2025. The place of performance is listed as the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2FMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,855.50 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml configurations. This firm fixed-price, competitively awarded contract was executed on August 6, 2025, with an ultimate completion date of August 7, 2025, and represents a pharmaceutical delivery to support federal medical procurement needs. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad spectrum of medications and medical supplies to support military healthcare systems globally, including products serving the Defense Health Agency and other federal healthcare customers. The award reflects AmerisourceBergen's established capability as a critical pharmaceutical distributor within the federal medical supply chain, with no set-aside designation applied to this competitive procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.9k | 8/6/25 |